Author

Chad M. Michener

Observed names: C Michener, C. M. Michener, C. Michener, C.M. MICHENER, C.M. Michener, CM Michener, Chad M Michener, Chad Michener, Michener, Chad, Michener, Chad M.

Institution: Cleveland Clinic

Observed institutions: National Institutes of Health, Albert Einstein College of Medicine, Cleveland Clinic, Center for Biologics Evaluation and Research, United States Food and Drug Administration, The University of Texas MD Anderson Cancer Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, Yale University, Cleveland Clinic Lerner College of Medicine, National Cancer Institute, Center for Cancer Research, Case Comprehensive Cancer Center, The Ohio State University, Case Western Reserve University

ORCID: 0000-0001-5170-6626

Observed ORCID: 0000-0001-5170-6626

OpenAlex ID: A5067090684

Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer

2022 · Laura M. Chambers, Emily L. Esakov Rhoades, et al. · Cancer Research · 128

Potential Markers for Detection and Monitoring of Ovarian Cancer

2011 · Brandon J. D. Rein, Sajal Gupta, et al. · Journal of Oncology · 110

PDF

CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors

2017 · Caner Saygin, Andrew Wiechert, et al. · The Journal of Experimental Medicine · 106

Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?

2017 · Amanda N. Fader, Jennifer Bergstrom, et al. · Gynecologic Oncology · 102

Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center

2013 · Jessica Moline, Haider Mahdi, et al. · Gynecologic Oncology · 102

Plagiarism and data falsification are the most common reasons for retracted publications in obstetrics and gynaecology

2019 · LM Chambers, CM Michener, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 99

PDF

The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer.

2003 · Monica Brown Jones, Chad M Michener, et al. · PubMed · 80

Endometrial cancer in young women: prognostic factors and treatment outcomes in women aged ≤40 years

2020 · Ji Son, Caitlin Carr, et al. · International Journal of Gynecological Cancer · 75

Germline PTEN , SDHB‐D , and KLLN alterations in endometrial cancer patients with Cowden and Cowden‐like syndromes: An international, multicenter, prospective study

2014 · Haider Mahdi, Jessica L. Mester, et al. · Cancer · 70

PDF

Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin–epithelin precursor (GEP), a prosurvival factor for ovarian cancer

2005 · Mitchell Kamrava, Fiona Simpkins, et al. · Oncogene · 70

Surgical Site Infection in Women Undergoing Surgery for Gynecologic Cancer

2014 · Haider Mahdi, Anar Gojayev, et al. · International Journal of Gynecological Cancer · 69

Genomics and proteomics: application of novel technology to early detection and prevention of cancer

2002 · Chad M Michener, Ali M Ardekani, et al. · Cancer Detection and Prevention · 69

The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities

2021 · Laura M. Chambers, Parker Bussies, et al. · Current Oncology Reports · 56

Retracted articles in the obstetrics literature: lessons from the past to change the future

2020 · Carrie Bennett, Laura M. Chambers, et al. · American Journal of Obstetrics & Gynecology MFM · 54

Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants

2023 · Lamis Yehia, Gilman Plitt, et al. · JAMA Network Open · 50

PDF

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial

2016 · H. J. Gray, B. Benigno, et al. · Journal for ImmunoTherapy of Cancer · 48

PDF

Laparoendoscopic Single-site Radical Hysterectomy With Pelvic Lymphadenectomy: Initial Multi-institutional Experience for Treatment of Invasive Cervical Cancer

2013 · David M. Boruta, Anna Fagotti, et al. · Journal of Minimally Invasive Gynecology · 47

Patterns of Recurrence in Stage I Endometrioid Endometrial Adenocarcinoma With Lymphovascular Space Invasion

2012 · Fiona Simpkins, Andrea Papadia, et al. · International Journal of Gynecological Cancer · 46

Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial carcinoma

2005 · Chad M. Michener, Gertrude Peterson, et al. · Journal of Cancer Research and Clinical Oncology · 45

Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high‐grade serous ovarian cancer

2015 · Mahrukh K. Ganapathi, Wendell D. Jones, et al. · International Journal of Cancer · 43

PDF

Single-port laparoscopy in gynecologic oncology: seven years of experience at a single institution

2017 · Laura Moulton, Amelia M. Jernigan, et al. · American Journal of Obstetrics and Gynecology · 41

CCL2 expression in primary ovarian carcinoma is correlated with chemotherapy response and survival outcomes.

2010 · Amanda Nickles Fader, Nabila Rasool, et al. · PubMed · 41

Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer

2019 · Elizabeth V. Connor, Caner Saygin, et al. · Journal of Ovarian Research · 40

PDF

Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer

2020 · Laura M. Chambers, Michelle Kuznicki, et al. · Gynecologic Oncology · 39

HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy

2018 · Katherine R. Miller, Jai N. Patel, et al. · Gynecologic Oncology · 38

Works count: 212

Citation count: 2,801

H-index: 32

I10-index: 67